Salmeterol
Last Updated: 02/24/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3008 publications
Pharmacometric-Based Evaluation of Salmeterol and Its Metabolite α-Hydroxysalmeterol in Plasma and Urine: Practical Implications for Doping Control.
Journal: CPT: pharmacometrics & systems pharmacology
Published: September 16, 2025
Biased Signaling and Its Role in the Genesis of Short- and Long-Acting β2-Adrenoceptor Agonists.
Journal: Biochemistry
Published: August 07, 2025
Brain-targeting nanocages treat Alzheimer's disease via regulating microglial polarization and remodeling microenvironment.
Journal: International journal of pharmaceutics
Published: July 19, 2025
Budesonide-Formoterol Metered-Dose Inhaler vs Fluticasone-Salmeterol Dry-Powder Inhaler.
Journal: JAMA internal medicine
Published: July 07, 2025
Drug-Associated Alcohol Intolerance: A Real-World Disproportionality Analysis Study.
Journal: Hospital pharmacy
Published: June 30, 2025
Mitigating End-Stage Fatigue: Acute Inhaled Salmeterol Preserves Sprint Power in Simulated Cycling.
Journal: Scandinavian journal of medicine & science in sports
Published: June 11, 2025
Development of a biorelevant dissolution method for inhalation products: Proof of concept using drugs with diverse solubilities.
Journal: ADMET & DMPK
Published: June 07, 2025
A Comparison of the Molecular Pharmacological Properties of Current Short, Long, and Ultra-Long-Acting β2-Agonists Used for Asthma and COPD.
Journal: Pharmacology research & perspectives
Published: May 28, 2025
Lung Deposition of Extrafine Versus Nonextrafine Aerosols at Low Inhalation Flow Rates in Adult Asthma Patients: A Composition Study.
Journal: Journal of aerosol medicine and pulmonary drug delivery
Published: May 13, 2025
Extracellular vesicles from bronchoalveolar lavage fluid provide insights into the inhaled corticosteroids treatment response in COPD.
Journal: Respiratory research
Published: April 15, 2025
Impact of Fluticasone Propionate and Salmeterol Combined with Pulmonary Rehabilitation on Pulmonary Function, Exercise Tolerance, and Quality of Life in Elderly Patients with Stable Chronic Obstructive Pulmonary Disease.
Journal: British journal of hospital medicine (London, England : 2005)
Published: March 26, 2025
Inhalable delivery of salmeterol xinafoate-ciclesonide co-amorphous for asthma treatment: prediction, preparation and evaluation.
Journal: International journal of pharmaceutics
Published: March 21, 2025
Last Updated: 02/24/2026